World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
86691
World Ranking
5408
National Ranking
157

Michel Komajda publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michel Komajda sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 509 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michel Komajda D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michel Komajda sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 110 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michel Komajda is affiliated with Université Paris Cité in France and has a research focus primarily in the field of Medicine, with significant contributions to Cardiology and Cardiovascular Medicine.

The main subjects of Komajda's research include Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, and Diabetes Treatment and Management. Additional topics investigated encompass Heart Rate and Cardiovascular Health, Healthcare Systems and Practices, Acute Myocardial Infarction Research, and Pancreatic Function and Diabetes.

Frequent coauthors collaborating with Komajda include Romain Cador, P. Abassade, Luigi Tavazzi, Gilles Châtellier, and Hélène Beaussier.

Komajda has published extensively in cardiovascular and heart failure research journals. Frequent publication venues include:

  • Archives of Cardiovascular Diseases Supplements
  • Archives of cardiovascular diseases
  • JACC Heart Failure
  • European Journal of Heart Failure
  • Annales de Cardiologie et d Angéiologie

Selected recent papers authored by or involving Michel Komajda are:

  • "Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure," 2020, New England Journal of Medicine
  • "Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction," 2020, Circulation
  • "Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial," 2021, Circulation
  • "Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23," 2021, European Heart Journal
  • "The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials," 2021, JACC Heart Failure

Best Publications

  • 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon

  • ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

    Kenneth Dickstein;Alain Cohen-Solal;Gerasimos Filippatos;John J V McMurray

  • Effects of Torcetrapib in Patients at High Risk for Coronary Events

    Philip J. Barter;Mark Caulfield;Mats Eriksson;Scott M Grundy

  • Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

    Karl Swedberg;John Cleland;Henry Dargie;Helmut Drexler

  • Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

    Karl Swedberg;Michel Komajda;Michael Böhm;Jeffrey S Borer

  • Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

    Philip A. Poole-Wilson;Karl Swedberg;John G.F. Cleland;Andrea Di Lenarda

  • Irbesartan in patients with heart failure and preserved ejection fraction

    Barry M. Massie;Peter E. Carson;John J. McMurray;Michel Komajda

  • The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.

    J.G.F Cleland;K Swedberg;F Follath;M Komajda

  • Rosuvastatin in Older Patients with Systolic Heart Failure

    John Kjekshus;Eduard Apetrei;Vivencio Barrios;Michael Böhm

  • Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

    Philip D. Home;Stuart J. Pocock;Henning Beck-Nielsen;Paula S. Curtis

  • EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.

    Markku S. Nieminen;Dirk Brutsaert;Kenneth Dickstein;Helmut Drexler

  • Effect of nesiritide in patients with acute decompensated heart failure.

    C. M. O'Connor;R. C. Starling;A. F. Hernandez;P. W. Armstrong

  • Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

    Deepak L. Bhatt;Michael Szarek;P. Gabriel Steg;Christopher P. Cannon

  • Hypertrophic Cardiomyopathy Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy

    Pascale Richard;Philippe Charron;Lucie Carrier;Céline Ledeuil

  • Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency

    Piotr Ponikowski;Dirk J. van Veldhuisen;Josep Comin-Colet;Georg Ertl

  • Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

    Michael Böhm;Karl Swedberg;Michel Komajda;Jeffrey S Borer

  • State of the art: using natriuretic peptide levels in clinical practice.

    Alan Maisel;Alan Maisel;Christian Mueller;Kirkwood Adams;Stefan D. Anker

  • Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.

    Philip D. Home;Stuart J. Pocock;Henning Beck-Nielsen;Ramón Gomis

  • Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice : a position statement of the ESC working group on myocardial and pericardial diseases

    Yigal M Pinto;Perry M Elliott;Eloisa Arbustini;Yehuda Adler

  • The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment.

    M. Komajda;F. Follath;K. Swedberg;J. Cleland

Frequent Co-Authors

Ketty Schwartz
Ketty Schwartz Grenoble Alpes University
Luigi Tavazzi
Luigi Tavazzi University of Ferrara
Robert S. McKelvie
Robert S. McKelvie University of Western Ontario
John J.V. McMurray
John J.V. McMurray University of Glasgow
Michael R. Zile
Michael R. Zile Medical University of South Carolina
Inder S. Anand
Inder S. Anand University of Minnesota
Karl Swedberg
Karl Swedberg University of Gothenburg
Gisèle Bonne
Gisèle Bonne Université Paris Cité
Ian Ford
Ian Ford University of Glasgow
Eloisa Arbustini
Eloisa Arbustini Policlinico San Matteo Fondazione

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens up a variety of online degree and certification options. If you’re looking to advance quickly in nursing, the 9 month lpn program offers a fast-track route to becoming a Licensed Practical Nurse, enabling you to start working sooner.

For nurses seeking leadership or advanced clinical roles, consider the convenience of a 1 year dnp program online. This allows registered nurses to earn a Doctor of Nursing Practice rapidly while balancing work and life commitments.

Those interested in mental health services should explore bsn to np programs online, which prepare candidates to become Psychiatric Mental Health Nurse Practitioners. These programs offer flexibility for bachelor’s-trained nurses wishing to specialize without delaying their careers.

Alternatively, if your interests lie more in the management and administrative side of healthcare, an online master of health administration degree can be a smart choice, providing essential skills for leadership roles in hospitals, clinics, and healthcare organizations.

Best Scientists Citing Michel Komajda

Trending Scientists

Recently Published Articles